Journal of Cancer Research and Clinical Oncology · 2021 · 10 citations · 20 references
MedicineDermatologyOncologyCancer ImmunologyImmunopathologyImmunotherapyCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint RegulationImmune CheckpointsMelanocytic TumorsDurable Clinical ResponseImmune Checkpoint Inhibitor BiomarkersImmune Checkpoint Inhibitor ResponseImmune Checkpoint Inhibitor TherapyImmune Checkpoint ResistanceMelanoma ImmunotherapyResistance To Checkpoint InhibitorsResistance To Immune Checkpoint Inhibition
20
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Wallace H. Clark, Lynn From, Evelina A. Bernardino et al. · PubMed · 1969 · 2.1K citations
Medicine, Dermatology, Pathology +17